Market

Half yearly Results

You can view the Halfyearly Results for the last 5 years.

HALF YEARLY RESULTS

GlaxoSmithKline Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 43218.87 P/BV 19.06 Book Value ( ₹ ) 133.85
52 Week High/Low ( ₹ ) 3220/2088 FV/ML 10/1 P/E(X) 41.72
Book Closure 29/05/2026 EPS ( ₹ ) 61.15 Div Yield (%) 2.23
(₹ in Crs.)

ParticularsMar 26Sep 25Mar 25Sep 24Mar 24
Net Sales/Income from operations2036.561785.111923.791825.421735.06
Total Income From Operations2036.561785.111923.791825.421735.06
      
EXPENDITURE     
Consumption of Raw Materials192.96243.19212.71287.19295.55
Purchase of Traded Goods445.67464.78455.63389.48418.26
Increase/Decrease in Stocks69.19-64.7342.763.09-29.84
Employees Cost316.63290.62277.71301.99314.18
Depreciation33.4932.9533.5233.2735.21
Other Expenses289.84264.32309.87291.42261.59
Total Expenses1347.781231.131332.201306.441294.95
      
P/L Before Other Inc. , Int., Excpt. Items & Tax688.78553.98591.59518.98440.11
Other Income68.0777.2975.7570.1857.94
P/L Before Interest, Excpt. Items & Tax756.85631.27667.34589.16498.05
Interest1.800.930.670.641.09
P/L Before Exceptional Items & Tax755.05630.34666.67588.52496.96
Exceptional Items17.982.640.004.69-160.91
P/L Before Tax773.03632.98666.67593.21336.05
Tax199.55170.48173.92158.3895.85
P/L After Tax from Ordinary Activities573.48462.50492.75434.83240.20
Net Profit/Loss For the Period573.48462.50492.75434.83240.20
Net P/L After Minority Interest & Share Of Associates573.48462.50492.75434.83240.20
      
Equity Share Capital169.41169.41169.41169.41169.41
EPS Before Extra Ordinary *     
Basic EPS (Rs.)33.8527.3029.0925.6714.18
Diluted EPS (Rs.)33.8527.3029.0925.6714.18
EPS After Extra Ordinary *     
Basic EPS (Rs.) 33.8527.3029.0925.6714.18
Diluted EPS (Rs.) 33.8527.3029.0925.6714.18
      
PBITOE Margin (%)33.8231.0330.7528.4325.36
PBTE Margin (%)37.0735.3134.6532.2428.64
PBT Margin (%)37.9535.4534.6532.4919.36
PAT Margin (%)28.1525.9025.6123.8213.84
PAT After MI And SOA Margin (%)28.1525.9025.6123.8213.84
ParticularsMar 26
Net Sales/Income from operations2036.56
Total Income From Operations2036.56
  
EXPENDITURE 
Consumption of Raw Materials192.96
Purchase of Traded Goods445.67
Increase/Decrease in Stocks69.19
Employees Cost316.63
Depreciation33.49
Other Expenses289.84
Total Expenses1347.78
P/L Before Other Inc. , Int., Excpt. Items & Tax688.78
Other Income68.07
P/L Before Interest, Excpt. Items & Tax756.85
Interest1.80
P/L Before Exceptional Items & Tax755.05
Exceptional Items17.98
P/L Before Tax773.03
Tax199.55
P/L After Tax from Ordinary Activities573.48
Net Profit/Loss For the Period573.48
Net P/L After Minority Interest & Share Of Associates573.48
Equity Share Capital169.41
EPS Before Extra Ordinary * 
Basic EPS (Rs.)33.85
Diluted EPS (Rs.)33.85
EPS After Extra Ordinary * 
Basic EPS (Rs.) 33.85
Diluted EPS (Rs.) 33.85
PBITOE Margin (%)33.82
PBTE Margin (%)37.07
PBT Margin (%)37.95
PAT Margin (%)28.15
PAT After MI And SOA Margin (%)28.15
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.